載入...
Dysregulation of KRAS signaling in pancreatic cancer is not associated with KRAS mutations and outcome
Pancreatic ductal adenocarcinoma (PDAC) is a tumor with a poor prognosis, and no targeted therapy is currently available. The aim of the present study was to investigate the prognostic significance of the expression of V-Ki-ras2 Κirsten rat sarcoma viral oncogene homolog (KRAS), downstream signaling...
Na minha lista:
| 發表在: | Oncol Lett |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
D.A. Spandidos
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5661609/ https://ncbi.nlm.nih.gov/pubmed/29113235 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6946 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|